Morgan Stanley Sells 15,454 Shares of Galapagos NV (NASDAQ:GLPG)
Morgan Stanley cut its stake in shares of Galapagos NV (NASDAQ:GLPG) by 22.8% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 52,426 shares of the biotechnology company’s stock after selling 15,454 shares during the period. Morgan Stanley’s holdings in Galapagos NV were worth $4,518,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors have also bought and sold shares of the company. Bank of Montreal Can raised its position in Galapagos NV by 8,736.4% in the first quarter. Bank of Montreal Can now owns 1,944 shares of the biotechnology company’s stock valued at $168,000 after buying an additional 1,922 shares during the last quarter. Cim Investment Mangement Inc. acquired a new position in Galapagos NV during the first quarter valued at approximately $203,000. Karp Capital Management Corp acquired a new position in Galapagos NV during the first quarter valued at approximately $206,000. UBS Group AG raised its position in Galapagos NV by 237.0% in the first quarter. UBS Group AG now owns 3,522 shares of the biotechnology company’s stock valued at $303,000 after buying an additional 2,477 shares during the last quarter. Finally, Airain ltd acquired a new position in Galapagos NV during the first quarter valued at approximately $237,000. 19.99% of the stock is owned by institutional investors and hedge funds.
Shares of Galapagos NV (GLPG) traded up 3.20% on Friday, reaching $83.65. 157,822 shares of the company were exchanged. The stock’s market capitalization is $4.26 billion. The company has a 50-day moving average price of $77.64 and a 200 day moving average price of $79.02. Galapagos NV has a 1-year low of $52.50 and a 1-year high of $94.88.
ILLEGAL ACTIVITY NOTICE: “Morgan Stanley Sells 15,454 Shares of Galapagos NV (NASDAQ:GLPG)” was published by Watch List News and is the property of of Watch List News. If you are viewing this piece of content on another domain, it was illegally copied and reposted in violation of U.S. & international trademark & copyright law. The original version of this piece of content can be accessed at https://www.watchlistnews.com/morgan-stanley-sells-15454-shares-of-galapagos-nv-nasdaqglpg/1475225.html.
Several research firms have recently commented on GLPG. Cowen and Company reissued a “buy” rating on shares of Galapagos NV in a research note on Thursday. Morgan Stanley reissued an “overweight” rating and issued a $92.00 price objective on shares of Galapagos NV in a research note on Thursday. Stifel Nicolaus raised shares of Galapagos NV from a “hold” rating to a “buy” rating and raised their price objective for the company from $83.00 to $101.00 in a research note on Friday. Janney Montgomery Scott raised shares of Galapagos NV from a “sell” rating to a “neutral” rating in a research note on Friday, July 7th. They noted that the move was a valuation call. Finally, BTIG Research reissued a “buy” rating and issued a $98.00 price objective on shares of Galapagos NV in a research note on Tuesday, June 20th. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating and eight have assigned a buy rating to the company’s stock. The company presently has a consensus rating of “Buy” and a consensus price target of $95.71.
Galapagos NV Company Profile
Galapagos NV is a Belgium-based biotechnology company. The Company’s activities are divided into two operating divisions: Research and Development (R & D) and Services. The R & D division is engaged in the discovery and development of small molecules. The Services division, offers target-to-drug discovery products and services to pharmaceutical and biotechnology companies and to patient foundations, encompassing target discovery and validation, screening and drug discovery through to delivery of pre-clinical candidates.
Want to see what other hedge funds are holding GLPG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Galapagos NV (NASDAQ:GLPG).
Receive News & Ratings for Galapagos NV Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Galapagos NV and related companies with Analyst Ratings Network's FREE daily email newsletter.